Back to Search Start Over

Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology ( <scp>SIOP</scp> ) 93‐01, 2001 and <scp>UK‐IMPORT</scp> database: A report of the <scp>SIOP‐Renal</scp> Tumor Study Group

Authors :
Janna A. Hol
Christina A. Hulsbergen-van de Kaa
Jens-Peter Schenk
Justine N. van der Beek
Gordan M. Vujanic
Manfred Gessler
Paola Collini
Maite E. Houwing
Marry M. van den Heuvel-Eibrink
Aurore Coulomb-L'Hermine
Jan Godzinski
Harm van Tinteren
Norbert Graf
Godelieve A.M. Tytgat
Tony Frisk
Barbara Selle
Gema L. Ramírez-Villar
Reem Al-Saadi
Bengt Sandstedt
Kristina Dzhuma
Beatriz de Camargo
Christian Ruebe
Christian Vokuhl
Kathy Pritchard-Jones
Dermot Murphy
Arnaud C. Verschuur
Ronald R. de Krijger
Annemieke S. Littooij
Satyajit Ray
Source :
International Journal of Cancer. 148:2724-2735
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

In children, renal cell carcinoma (RCC) is rare. This study is the first report of pediatric patients with RCC registered by the International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG). Pediatric patients with histologically confirmed RCC, registered in SIOP 93-01, 2001 and UK-IMPORT databases, were included. Event-free survival (EFS) and overall survival (OS) were analyzed using the Kaplan-Meier method. Between 1993 and 2019, 122 pediatric patients with RCC were registered. Available detailed data (n = 111) revealed 56 localized, 30 regionally advanced, 25 metastatic and no bilateral cases. Histological classification according to World Health Organization 2004, including immunohistochemical and molecular testing for transcription factor E3 (TFE3) and/or EB (TFEB) translocation, was available for 65/122 patients. In this group, the most common histological subtypes were translocation type RCC (MiT-RCC) (36/64, 56.3%), papillary type (19/64, 29.7%) and clear cell type (4/64, 6.3%). One histological subtype was not reported. In the remaining 57 patients, translocation testing could not be performed, or TFE-cytogenetics and/or immunohistochemistry results were missing. In this group, the most common RCC histological subtypes were papillary type (21/47, 44.7%) and clear cell type (11/47, 23.4%). Ten histological subtypes were not reported. Estimated 5-year (5y) EFS and 5y OS of the total group was 70.5% (95% CI = 61.7%-80.6%) and 84.5% (95% CI = 77.5%-92.2%), respectively. Estimated 5y OS for localized, regionally advanced, and metastatic disease was 96.8%, 92.3%, and 45.6%, respectively. In conclusion, the registered pediatric patients with RCC showed a reasonable outcome. Survival was substantially lower for patients with metastatic disease. This descriptive study stresses the importance of full, prospective registration including TFE-testing.

Details

ISSN :
10970215 and 00207136
Volume :
148
Database :
OpenAIRE
Journal :
International Journal of Cancer
Accession number :
edsair.doi...........2ed93b7f538f0bcaeedeb5694d04954c